Seow, Jeffrey et al. (2020). Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. doi: 10.1101/2020.07.09.20148429.

Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

Malferheiner, Sara et al. (2020) Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study doi: 10.1016/j.jcv.2020.104575

Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study


Hu WT, Howell JC, Ozturk T, et al. Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 [published online ahead of print, 2020 Aug 28]. Emerg Infect Dis. 2020;
doi:10.3201/eid2612.203334

Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA

Princeton University

Northwestern University

- Antibody Therapeutics
-  MedRxiv Preprint Papers
- Preprints
- Science

References for Antibodies and COVID-19 by journal

Preprints Papers of Articles Related to Antibodies and COVID-19

-  Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
- SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
-  Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–[negative] implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
- Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers. 

MedRxiv Preprint Papers Related to SARS-CoV-2 Antibody Testing

- Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective 

Antibody Therapeutics Papers Related to Antibodies and COVID-19

- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- Structural basis of a shared antibody response
to SARS-CoV-2

Learn Before

Related

Learn After